Eagle Global Advisors LLC Buys Shares of 224,000 Haleon plc (NYSE:HLN)

Eagle Global Advisors LLC bought a new position in shares of Haleon plc (NYSE:HLN - Free Report) in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm bought 224,000 shares of the company's stock, valued at approximately $2,137,000.

A number of other hedge funds also recently modified their holdings of HLN. Addison Advisors LLC raised its holdings in shares of Haleon by 28.7% during the 4th quarter. Addison Advisors LLC now owns 4,954 shares of the company's stock worth $47,000 after buying an additional 1,106 shares in the last quarter. Haverford Trust Co raised its holdings in shares of Haleon by 5.0% during the 4th quarter. Haverford Trust Co now owns 25,842 shares of the company's stock worth $247,000 after buying an additional 1,233 shares in the last quarter. Bessemer Group Inc. raised its holdings in shares of Haleon by 5.9% during the 4th quarter. Bessemer Group Inc. now owns 22,301 shares of the company's stock worth $212,000 after buying an additional 1,236 shares in the last quarter. United Capital Financial Advisors LLC raised its holdings in shares of Haleon by 3.5% during the 4th quarter. United Capital Financial Advisors LLC now owns 37,475 shares of the company's stock worth $358,000 after buying an additional 1,266 shares in the last quarter. Finally, FIL Ltd increased its position in Haleon by 45.7% during the 4th quarter. FIL Ltd now owns 4,049 shares of the company's stock worth $39,000 after purchasing an additional 1,270 shares in the last quarter. Institutional investors and hedge funds own 6.67% of the company's stock.

Haleon Trading Down 2.4%

NYSE HLN traded down $0.26 during trading hours on Tuesday, hitting $10.45. 12,727,914 shares of the company's stock were exchanged, compared to its average volume of 7,838,241. The stock has a 50-day simple moving average of $10.21 and a 200 day simple moving average of $9.84. Haleon plc has a 1-year low of $8.24 and a 1-year high of $10.85. The firm has a market cap of $47.13 billion, a price-to-earnings ratio of 30.74, a PEG ratio of 2.82 and a beta of 0.24. The company has a current ratio of 0.84, a quick ratio of 0.58 and a debt-to-equity ratio of 0.44.

Haleon (NYSE:HLN - Get Free Report) last posted its quarterly earnings results on Thursday, February 27th. The company reported $0.05 EPS for the quarter. The business had revenue of $3.54 billion during the quarter, compared to analysts' expectations of $3.38 billion. Haleon had a net margin of 10.85% and a return on equity of 14.76%. On average, equities analysts forecast that Haleon plc will post 0.43 EPS for the current fiscal year.

Haleon Increases Dividend

The business also recently announced a -- dividend, which will be paid on Thursday, June 5th. Stockholders of record on Friday, April 25th will be issued a $0.1166 dividend. This represents a dividend yield of 1.6%. The ex-dividend date of this dividend is Friday, April 25th. This is a positive change from Haleon's previous -- dividend of $0.05. Haleon's dividend payout ratio (DPR) is currently 58.97%.

Analysts Set New Price Targets

HLN has been the subject of a number of research analyst reports. Hsbc Global Res cut shares of Haleon from a "strong-buy" rating to a "hold" rating in a research report on Wednesday, March 5th. Deutsche Bank Aktiengesellschaft reaffirmed a "hold" rating on shares of Haleon in a report on Monday, March 3rd. HSBC reaffirmed a "hold" rating on shares of Haleon in a report on Wednesday, March 5th. Barclays restated an "overweight" rating on shares of Haleon in a research report on Tuesday, May 6th. Finally, Morgan Stanley upgraded shares of Haleon from an "equal weight" rating to an "overweight" rating and set a $11.25 price target for the company in a research report on Friday. Five research analysts have rated the stock with a hold rating, three have assigned a buy rating and one has issued a strong buy rating to the company's stock. According to MarketBeat, the company presently has an average rating of "Moderate Buy" and an average target price of $11.25.

Haleon Company Profile

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.